Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WAS protein family homolog 4 pseudogene (WASH4P) is classified as a pseudogene, meaning it is a genomic DNA sequence that is similar to a known gene but carries mutations or deletions that prevent it from producing a functional protein[1][4][6][7]. It is annotated in gene databases as having predicted activities, such as actin and tubulin binding, reflecting ancestral relationships to the functional WASP family proteins, which are involved in actin nucleation and cytoskeletal dynamics[1]. However, due to its disabled coding sequence, WASH4P does not have an experimentally confirmed biological function or direct clinical relevance[1][4][7]. Pseudogenes like WASH4P may have regulatory roles in rare cases (e.g., through non-coding RNA or as microRNA decoys), but no data support WASH4P in such roles[4][8]. It is not a recognized receptor, enzyme, transporter, or therapeutic target, and therefore does not interact with drugs nor present specific safety or biomarker implications[1][6]. The inclusion of this pseudogene as a "target" is incorrect from the standpoint of drug discovery or therapeutic intervention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WASP family homolog 4, pseudogene (WASH4P).